Skip to main content

Table 2 miRNAs differentially expressed between normal colon and early stage colorectal cancer (Stages I and II).

From: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

miRNA

Normal

Stage I/II

Fold change

p-value

hsa-miR-224

6.89

8.67

3.45

1.80E-02

hsa-miR-21

13.02

14.49

2.78

1.52E-04

hsa-miR-34a

9.48

10.43

1.92

1.92E-02

hsa-miR-106a

10.68

11.57

1.85

2.88E-02

hsa-miR-18a

7.51

8.38

1.83

3.32E-02

hsa-miR-29b

9.70

10.56

1.82

3.27E-03

hsa-miR-19b

10.84

11.69

1.80

2.77E-02

hsa-miR-106b

9.45

10.26

1.76

1.37E-02

hsa-miR-20a

9.28

10.06

1.72

3.75E-02

hsa-miR-29a

12.14

12.89

1.68

9.84E-04

hsa-miR-181b

8.41

9.11

1.63

9.47E-03

hsa-miR-19a

7.78

8.45

1.60

2.58E-02

hsa-miR-95

6.12

6.79

1.59

3.33E-02

hsa-miR-516-3p

4.87

5.52

1.57

3.20E-02

hsa-miR-378*

7.53

6.85

0.62

1.87E-03

hsa-miR-422b

10.88

10.02

0.55

4.91E-03

hsa-miR-422a

10.05

9.19

0.55

9.57E-03

hsa-miR-30a-3p

7.14

6.24

0.54

1.51E-02

hsa-miR-139

7.62

6.17

0.37

5.75E-03

hsa-miR-195

11.04

9.52

0.35

2.37E-02

hsa-miR-145

15.11

13.46

0.32

4.30E-02

hsa-miR-133a

10.51

7.64

0.14

3.00E-02

  1. Fold change = cancer:normal